Palvella Therapeutics, Inc. (PVLA) stock
PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
$146.58+2.23 (+1.54%)
Close on Nov 18, 2026Market cap $2.11BP/E –Yield –
Palvella Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Palvella Therapeutics's price to book ratio was 10.9× on Nov 11, 2026, against 29.5× a year earlier. Over the last 5 years it ranged from 0.5× to 59.7×, with a median of 4.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.9× | −19.1 |
| 2025 | Dec 31, 2025 | 30.0× | +29.5 |
| 2024 | Jan 31, 2024 | 0.5× | +0.0 |
| 2023 | Dec 29, 2023 | 0.5× | −1.7 |
| 2022 | Dec 30, 2022 | 2.2× | −2.9 |
| 2021 | Dec 31, 2021 | 5.0× | +1.8 |
| 2020 | Dec 31, 2020 | 3.2× | −5.5 |
| 2019 | Dec 31, 2019 | 8.7× | +5.8 |
| 2018 | Dec 31, 2018 | 2.9× | −71.2 |
| 2017 | Dec 29, 2017 | 74.0× | +72.1 |
| 2016 | Dec 30, 2016 | 1.9× | −0.8 |
| 2015 | Dec 31, 2015 | 2.7× | – |
See a number that looks wrong?